197 related articles for article (PubMed ID: 20840725)
1. Identifying dysfunctional crosstalk of pathways in various regions of Alzheimer's disease brains.
Liu ZP; Wang Y; Zhang XS; Chen L
BMC Syst Biol; 2010 Sep; 4 Suppl 2(Suppl 2):S11. PubMed ID: 20840725
[TBL] [Abstract][Full Text] [Related]
2. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
Wang M; Roussos P; McKenzie A; Zhou X; Kajiwara Y; Brennand KJ; De Luca GC; Crary JF; Casaccia P; Buxbaum JD; Ehrlich M; Gandy S; Goate A; Katsel P; Schadt E; Haroutunian V; Zhang B
Genome Med; 2016 Nov; 8(1):104. PubMed ID: 27799057
[TBL] [Abstract][Full Text] [Related]
3. Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.
Hu YS; Xin J; Hu Y; Zhang L; Wang J
Alzheimers Res Ther; 2017 Apr; 9(1):29. PubMed ID: 28446202
[TBL] [Abstract][Full Text] [Related]
4. Detecting and analyzing differentially activated pathways in brain regions of Alzheimer's disease patients.
Liu ZP; Wang Y; Zhang XS; Xia W; Chen L
Mol Biosyst; 2011 May; 7(5):1441-52. PubMed ID: 21336338
[TBL] [Abstract][Full Text] [Related]
5. Pathway crosstalk analysis of microarray gene expression profile in human hepatocellular carcinoma.
Zhou X; Zheng R; Zhang H; He T
Pathol Oncol Res; 2015 Jul; 21(3):563-9. PubMed ID: 25480734
[TBL] [Abstract][Full Text] [Related]
6. AlzPathway, an Updated Map of Curated Signaling Pathways: Towards Deciphering Alzheimer's Disease Pathogenesis.
Ogishima S; Mizuno S; Kikuchi M; Miyashita A; Kuwano R; Tanaka H; Nakaya J
Methods Mol Biol; 2016; 1303():423-32. PubMed ID: 26235082
[TBL] [Abstract][Full Text] [Related]
7. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease.
Mendonça CF; Kuras M; Nogueira FCS; Plá I; Hortobágyi T; Csiba L; Palkovits M; Renner É; Döme P; Marko-Varga G; Domont GB; Rezeli M
Neurobiol Dis; 2019 Oct; 130():104509. PubMed ID: 31207390
[TBL] [Abstract][Full Text] [Related]
8. An integrated approach to unravel a putative crosstalk network in Alzheimer's disease and Parkinson's disease.
Bisht I; Ambasta RK; Kumar P
Neuropeptides; 2020 Oct; 83():102078. PubMed ID: 32807513
[TBL] [Abstract][Full Text] [Related]
9. Molecular differences in Alzheimer's disease between male and female patients determined by integrative network analysis.
Sun LL; Yang SL; Sun H; Li WD; Duan SR
J Cell Mol Med; 2019 Jan; 23(1):47-58. PubMed ID: 30394676
[TBL] [Abstract][Full Text] [Related]
10. Investigating Pathogenetic Mechanisms of Alzheimer's Disease by Systems Biology Approaches for Drug Discovery.
Yeh SJ; Chung MH; Chen BS
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681938
[TBL] [Abstract][Full Text] [Related]
11. AlzPathway: a comprehensive map of signaling pathways of Alzheimer's disease.
Mizuno S; Iijima R; Ogishima S; Kikuchi M; Matsuoka Y; Ghosh S; Miyamoto T; Miyashita A; Kuwano R; Tanaka H
BMC Syst Biol; 2012 May; 6():52. PubMed ID: 22647208
[TBL] [Abstract][Full Text] [Related]
12. A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging.
Miller JA; Oldham MC; Geschwind DH
J Neurosci; 2008 Feb; 28(6):1410-20. PubMed ID: 18256261
[TBL] [Abstract][Full Text] [Related]
13. Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia.
Pasinetti GM
J Neurosci Res; 2001 Sep; 65(6):471-6. PubMed ID: 11550214
[TBL] [Abstract][Full Text] [Related]
14. Systems modeling of white matter microstructural abnormalities in Alzheimer's disease.
Horgusluoglu-Moloch E; Xiao G; Wang M; Wang Q; Zhou X; Nho K; Saykin AJ; Schadt E; Zhang B;
Neuroimage Clin; 2020; 26():102203. PubMed ID: 32062565
[TBL] [Abstract][Full Text] [Related]
15. Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.
Liang WS; Dunckley T; Beach TG; Grover A; Mastroeni D; Ramsey K; Caselli RJ; Kukull WA; McKeel D; Morris JC; Hulette CM; Schmechel D; Reiman EM; Rogers J; Stephan DA
Physiol Genomics; 2008 Apr; 33(2):240-56. PubMed ID: 18270320
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's as a Systems-Level Disease Involving the Interplay of Multiple Cellular Networks.
Castrillo JI; Oliver SG
Methods Mol Biol; 2016; 1303():3-48. PubMed ID: 26235058
[TBL] [Abstract][Full Text] [Related]
17. Single cell gene expression profiling in Alzheimer's disease.
Ginsberg SD; Che S; Counts SE; Mufson EJ
NeuroRx; 2006 Jul; 3(3):302-18. PubMed ID: 16815214
[TBL] [Abstract][Full Text] [Related]
18. The construction of common and specific significance subnetworks of Alzheimer's disease from multiple brain regions.
Kong W; Mou X; Zhang N; Zeng W; Li S; Yang Y
Biomed Res Int; 2015; 2015():394260. PubMed ID: 25866779
[TBL] [Abstract][Full Text] [Related]
19. Condition-specific gene co-expression network mining identifies key pathways and regulators in the brain tissue of Alzheimer's disease patients.
Xiang S; Huang Z; Wang T; Han Z; Yu CY; Ni D; Huang K; Zhang J
BMC Med Genomics; 2018 Dec; 11(Suppl 6):115. PubMed ID: 30598117
[TBL] [Abstract][Full Text] [Related]
20. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
